None of the genes in the novel EC–BC loci have been previously reported as hormonal modifiers, but the G protein-coupled estrogen receptor signaling has been suggested to suppress PIEZO1, which may influence proliferation [49]. The gene discussed is PIEZO1; the disease is breast cancer.